Skip to main content

Table 1 Baseline clinical characteristics of the study participants with or without atrial fibrillation

From: Elevated plasma Ninjurin-1 levels in atrial fibrillation is associated with atrial remodeling and thromboembolic risk

 

Control

AF

P value

Number

51

96

AF history, years

-

4.35 ± 6.51

Male (%)

21 (41.18%)

56 (58.33%)

0.057

HTN (%)

26 (50.98%)

58 (60.42%)

0.297

DM (%)

7 (13.73%)

26 (27.08%)

0.096

CAD (%)

2 (3.92%)

10 (10.42%)

0.218

Smoking (%)

15 (29.41%)

17 (17.71%)

0.141

Drinking (%)

12 (23.53%)

16 (16.67%)

0.378

Age, years

65.00 (55.00, 68.00)

66.00 (60.00, 72.00)

0.039*

BMI, kg/m2

26.23 ± 3.32

25.68 ± 3.27

0.411

WBC, × 109/L

6.31 ± 1.19

6.05 ± 1.43

0.417

HGB, g/L

129.65 ± 14.69

138.77 ± 16.30

0.016*

PLT, × 109/L

221.78 ± 43.40

201.92 ± 60.16

0.139

TC, mmol/L

4.05 ± 0.95

4.05 ± 0.89

0.986

TG, mmol/L

1.08 (0.88, 1.81)

1.18 (0.88, 1.49)

0.873

LDL-C, mmol/L

2.52 ± 0.85

2.62 ± 0.87

0.519

HDL-C, mmol/L

1.19 ± 0.29

1.09 ± 0.32

0.079

AST, U/L

18.55 ± 5.78

20.43 ± 7.49

0.159

ALT, U/L

16.00 (12.25, 20.95)

17.00 (13.25, 23.00)

0.544

sCr, μmol/L

67.48 ± 14.55

70.97 ± 15.01

0.215

cTNI, ng/mL

0.00 (0.00, 0.01)

0.00 (0.00, 0.01)

0.662

HbA1c (%)

5.90 (5.70, 6.20)

5.90 (5.70, 6.55)

0.921

LVEF (%)

68.38 ± 5.20

64.28 ± 6.67

0.001**

LAVI, ml/m2

19.16 (15.08, 21.83)

26.90 (19.83, 32.27)

< 0.001***

ESR, mm/h

4.00 (2.50, 9.50)

4.00 (2.00, 8.00)

0.460

  1. Data are presented as mean ± SD, median (quartile) or number (%). ALT, alanine aminotransfease; AST, aspartate aminotransferase; BMI, body mass index; cTNI, cardiac troponin I; CAD, coronary artery disease; DM, diabetes mellitus; ESR, erythrocyte sedimentation rate; HTN, hypertension; HDL-C, high density lipoprotein cholesterol; HGB, hemoglobin; HbA1c, hemoglobin A1c; LDL-C, low density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; LAVI, left atrial volume index; PLT, platelet; sCr, serum creatinine; TC, total cholesterol; TG, triglyceride; WBC, white blood cell
  2. *P < 0.05; **P < 0.01; ***P < 0.001